Market Tracker

05/29 10:02pm ET

Mylan NV (NASDAQ:MYL)

72.63
Delayed Data
As of May 29
 -0.05 / -0.07%
Today’s Change
44.80
Today|||52-Week Range
76.69
+28.85%
Year-to-Date

Today’s Trading

Previous close72.68
Today’s open72.73
Day’s range72.56 - 73.86
Volume7,327,921
Average volume (3 months)9,399,456
Market cap$35.6B
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+15.44%
Earnings growth (next 5 years)+10.37%
Revenue growth (last year)+12.42%
P/E ratio31.3
Price/Sales2.71
Price/Book8.38

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-2.35-1.41%
VRTXVertex Pharmaceutica...+0.89+0.70%
PRGOPerrigo Company PLC-3.66-1.89%
ZTSZoetis Inc+0.66+1.34%
Data as of 4:14pm ET, 05/29/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)$0.92
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts